Details
|
Adolor Corp is a biopharmaceutical company specializing in the development, discovery and commercialization of novel prescription pain management products. Adolor's major product candidate is Entereg under development for the management of the gastrointestinal side effects associated with opioid use. The company's other product candidate is a steril lidocain patch, which is used for treating postoperative pain. Its other products include analgesics for treatment of moderate to severe pain combinations. Adolor collaborates with GlaxoSmithKline for the worldwide development and commercialization of Entereg for postoperative ileus, opioid-induced bowel dysfunction associated with extended use of irritable bowel syndrome, chronic constipation and other. By applying its knowledge and expertise in pain management, the company is looking to make a positive difference for patients, medical community and caregivers. Adolor was established in 1993 and is located in Exton, Pennsylvania.
|
